Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2503 USD | -0.87% | +0.04% | -88.19% |
Mar. 28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.19% | 2.79M | |
+2.16% | 42.75B | |
+47.70% | 41.61B | |
+11.41% | 41.34B | |
-12.36% | 26.59B | |
+8.22% | 25.49B | |
-23.01% | 18.12B | |
+30.86% | 12.24B | |
-1.56% | 11.76B | |
+8.39% | 11B |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- Endra Life Sciences Says de Novo Application for TAEUS Monitor Due in 'Coming Weeks'